|
WO2008048646A1
|
|
Use of human protein c with altered glycosylation and sialic acid content as a medicament
|
|
WO2007059103A2
|
|
Serum response factor and myocardin control alzheimer cerebral amyloid angiopathy
|
|
EP1909574A2
|
|
Role of gax in alzheimer neurovascular dysfunction
|
|
WO2004056309A2
|
|
Neuroprotective activity of activated protein c is independent of its anticoagulant activity
|
|
CA2508276A1
|
|
Neuroprotective activity of activated protein c is independent of its anticoagulant activity
|
|
AU2003277034A8
|
|
Protein s protects the nervous system from injury
|
|
AU2003248660A8
|
|
Treatment of vascular dysfunction and alzheimer's disease
|
|
WO02057496A2
|
|
Gene expression profiling of endothelium in alzheimer's disease
|
